Deripen 169.4mg/50.6mg Injection
Marketer
Morepen Laboratories Ltd
Salt Composition
Etofylline (169.4mg) + Theophylline (50.6mg)
Overview Deripen 169.4mg/50.6mg Injection
Respirolin, a 169.4mg/50.6mg injectable solution, is indicated for asthma and chronic obstructive pulmonary disease (COPD), a lung condition characterized by airflow restriction. It facilitates bronchial muscle relaxation, thereby improving breathing. Administration is by a physician or registered nurse; dosage is individualized based on patient response and disease severity. Continuous use, as directed by your doctor, is crucial; premature discontinuation may lead to symptom recurrence and disease exacerbation. Inform your healthcare provider of all concurrent medications, as interactions are possible. Commonly reported side effects include nausea, vomiting, dyspepsia, headache, and agitation; these are typically transient. Report any concerning side effects immediately to your doctor. Prior to treatment, disclose any pre-existing cardiac, renal, or hepatic conditions to allow for appropriate dosage adjustment. Pregnancy, pregnancy planning, or breastfeeding should also be reported to your physician.
Primary Ingredients of Deripen 169.4mg/50.6mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Deripen 169.4mg/50.6mg Injection
Managing Chronic Obstructive Pulmonary Disease (COPD)
Major Benefits of Deripen 169.4mg/50.6mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Deripen 169.4mg/50.6mg Injection:
- Nausea
- Vomiting
- Headache
- Restlessness
How to use Deripen 169.4mg/50.6mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Deripen 169.4mg/50.6mg Injection works:
Etofylline and theophylline, combined in Deripen 169.4mg/50.6mg Injection, act as bronchodilators. Their mechanism involves airway muscle relaxation, leading to wider airways and improved breathing.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Deripen 169.4mg/50.6mg Injection poses a significant safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Deripen 169.4mg/50.6mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Lactation is compatible with Deripen 169.4mg/50.6mg Injection. Research in humans indicates negligible transfer of the medication into breast milk, posing no apparent risk to the infant. A precautionary measure to minimize infant exposure is to delay breastfeeding for two to four hours following administration of Deripen 169.4mg/50.6mg Injection.
DrivingCONSULT YOUR DOCTOR
The effect of Deripen 169.4mg/50.6mg Injection on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Deripen 169.4mg/50.6mg Injection's application in individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should use Deripen 169.4mg/50.6mg Injection cautiously. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Deripen 169.4mg/50.6mg Injection :
Omitting a scheduled dose of Deripen 169.4mg/50.6mg Injection necessitates contacting your physician.
Facts to Know About Deripen 169.4mg/50.6mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Breathing |
3,018 People bought this recently